By Mackenzie Tatananni

Medical device maker Medtronic posted earnings and net sales that topped consensus views. The stock declined in premarket trading Tuesday.

Medtronic reported fiscal third-quarter adjusted earnings of $1.36 a share, narrowly beating analysts' forecasts of $1.34. Net sales were $9 billion, topping Wall Street's calls for $8.9 billion.

However, Medtronic left its fiscal-year guidance unchanged. The company sees earnings in the range of $5.62 to $5.66 a share, slightly below analysts' calls for $5.65 a share at the midpoint. The outlook includes a potential $185 million blow from tariffs, the company said.

Shares initially rose in premarket trading before reversing course and falling 3.8% to $95.70. Futures tracking the benchmark S&P 500 ticked down 0.3%.

Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

February 17, 2026 07:05 ET (12:05 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.